Title VIII Nursing Workforce Reauthorization Act of 2025
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
This bill reauthorizes programs designed to develop the nursing workforce in the United States. Specifically, it amends the Public Health Service Act to expand the types of nursing education programs eligible for grants, including nurse practitioner, nurse-midwifery, nurse anesthesia, and clinical nurse specialist programs. It also strengthens capacity for nurse education by updating funding for equipment and resources, and by encouraging partnerships between schools of nursing and healthcare facilities to expand clinical education opportunities.
Key provisions
- Expands eligible nursing education programs for grant funding.
- Replaces ‘midwives’ with ‘nurse-midwives’ in relevant sections.
- Increases funding for nursing education programs from $137.837 million to $184.337 million annually for fiscal years 2026-2030.
- Authorizes funding for telehealth technologies and simulation resources in nursing education.
- Encourages partnerships between schools of nursing and healthcare facilities.
- Updates funding for Part D of title VIII of the Public Health Service Act.
- Increases funding for clinical education.
- Expands the scope of survivors considered in domestic violence programs.
Who is affected
- Nursing students and faculty
- Healthcare facilities
- Nurse practitioners
- Nurse-midwives
- Clinical nurse specialists
Notable changes
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
13 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours